Journal of Biological Chemistry · 1995 · 42 citations · 27 references
Life SciencesBiochemistryCellular MetabolismEnzymologyMetabolismBiotransformation PathwaysCarcinogen MetabolismCatalytic Activity AssaysSulfotransferase ActivitySulfotransferase Enzyme SpecificitySulfur Metabolism EnzymesSulfurtransferase Activity
Three aryl sulfotransferases (ASTs) isolated from rat liver catalyze the sulfuric acid esterification of the carcinogen N-hydroxy-2-acetylaminofluorene (N-OH-2AAF). These three ASTs were separated by high resolution anion exchange chromatography and were designated Q1, Q2, and Q3. Q1 and Q2 had high N-OH-2AAF sulfonation activity, whereas Q3 showed low activity. Reversed phase high performance liquid chromatography/mass spectrometry analysis showed Q1-Q3 to be comprised of 33,945- and 35,675-Da protein subunits. Q1 contained only the 35,675-Da protein subunit, Q2 contained equal quantities of 33,945- and 35,675-Da subunits, and Q3 contained only the 33,945-Da subunit. The subunit compositions of Q1-Q3 were confirmed by immunochemical analysis. Size exclusion high performance liquid chromatography confirmed that the active quaternary structure of the three isoenzymes was dimeric. Analysis of liver cytosols for the relative contributions of Q1-Q3 to total cytosolic N-OH-2AAF sulfotransferase activity indicated that Q1, Q2, and Q3 accounted for 44, 46, and 10% of the activity, respectively. These results demonstrate the existence of both homodimeric and heterodimeric aryl sulfotransferases and show that two ASTs, a homodimer of 35,675-Da subunits and a heterodimer of a 33,945- and a 35,675-Da subunit, are primarily responsible for hepatic N-OH-2AAF sulfotransferase activity. Three aryl sulfotransferases (ASTs) isolated from rat liver catalyze the sulfuric acid esterification of the carcinogen N-hydroxy-2-acetylaminofluorene (N-OH-2AAF). These three ASTs were separated by high resolution anion exchange chromatography and were designated Q1, Q2, and Q3. Q1 and Q2 had high N-OH-2AAF sulfonation activity, whereas Q3 showed low activity. Reversed phase high performance liquid chromatography/mass spectrometry analysis showed Q1-Q3 to be comprised of 33,945- and 35,675-Da protein subunits. Q1 contained only the 35,675-Da protein subunit, Q2 contained equal quantities of 33,945- and 35,675-Da subunits, and Q3 contained only the 33,945-Da subunit. The subunit compositions of Q1-Q3 were confirmed by immunochemical analysis. Size exclusion high performance liquid chromatography confirmed that the active quaternary structure of the three isoenzymes was dimeric. Analysis of liver cytosols for the relative contributions of Q1-Q3 to total cytosolic N-OH-2AAF sulfotransferase activity indicated that Q1, Q2, and Q3 accounted for 44, 46, and 10% of the activity, respectively. These results demonstrate the existence of both homodimeric and heterodimeric aryl sulfotransferases and show that two ASTs, a homodimer of 35,675-Da subunits and a heterodimer of a 33,945- and a 35,675-Da subunit, are primarily responsible for hepatic N-OH-2AAF sulfotransferase activity. Cytosolic sulfotransferases have been shown to catalyze the PAPS 1The abbreviations used are: PAPS3′-phosphoadenosine-5′-phosphosulfateASTaryl sulfotransferaseHASThydroxylamine sulfotransferaseHPLChigh performance liquid chromatographyN-OH-2AAFN-hydroxy-2-acetylaminofluoreneLCliquid chromatographyPSTphenol sulfotransferasePAGEpolyacrylamide gel electrophoresis. -dependent sulfonation of a wide variety of hydroxylated endobiotic and xenobiotic compounds (1Jakoby W.B. Sekura R.D. Lyon E.S. Marcus C.J. Wang J. Jacoby W.B. Enzymatic Basis of Detoxication. Academic Press, New York1980: 199-228Crossref Google Scholar, 2Mulder G.J. Jakoby W.B. Mulder G.J. Conjugation Reactions in Drug Metabolism. Taylor & Francis Ltd., New York1990: 107-162Google Scholar, 3Webb E.C. Enzyme Nomenclature. Academic Press, New York1992: 299-303Google Scholar, 4Meerman J.H.N. Runge-Morris M.A. Coughtrie M.W.H. Chem. Biol. Interact.1994: 1-378Google Scholar). Whereas the primary function of xenobiotic sulfoconjugation is to permit detoxication of the compound, it occasionally results in the production of highly reactive intermediates capable of causing genotoxic and cytotoxic damage to cells. One sulfotransferase activity that has been studied with great interest is that responsible for the sulfoconjugation of N-hydroxyarylamic acids and N-hydroxyarylamines(5Miller E.C. Miller J.A. Cancer. 1981; 47: 2327-2345Crossref PubMed Scopus (782) Google Scholar, 6Miller E.C. Miller J.A. Boberg E.W. Delclos K.B. Lai C.-C. Fennell T.R. Wiseman R.W. Liem A. Huberman E. Barr S.H. Carcinogenesis. Raven Press, New York1985: 93-107Google Scholar, 7Kato R. Yamazoe Y. Drug Metab. Rev. 1994; 26: 413-430Crossref PubMed Scopus (40) Google Scholar). The sulfuric acid esterification of these compounds results in bioactivated forms reported to cause liver cancer in rodents(6Miller E.C. Miller J.A. Boberg E.W. Delclos K.B. Lai C.-C. Fennell T.R. Wiseman R.W. Liem A. Huberman E. Barr S.H. Carcinogenesis. Raven Press, New York1985: 93-107Google Scholar, 7Kato R. Yamazoe Y. Drug Metab. Rev. 1994; 26: 413-430Crossref PubMed Scopus (40) Google Scholar, 8DeBaun J.R. Miller E.C. Miller J.A. Cancer Res. 1970; 30: 577-595PubMed Google Scholar, 9Ringer D.P. Norton T.R. Cox B. Howell B.A. Cancer Lett. 1988; 40: 247-255Crossref PubMed Scopus (15) Google Scholar, 10Lai C.C. Miller J.A. Miller E.C. Liem A. Carcinogenesis. 1985; 6: 1037-1045Crossref PubMed Scopus (113) Google Scholar). A model compound for this class of carcinogens that has been extensively investigated is N-OH-2AAF. Sulfuric acid esters of N-OH-2AAF have been implicated in the in vivo production of the N-(deoxyguanosin-8-yl)- and 3-(deoxyguanosin-N2-yl)-2AAF DNA adducts in rat liver (11Meerman J.H.N. Beland F.A. Mulder G.J. Carcinogenesis. 1981; 2: 413-416Crossref PubMed Scopus (90) Google Scholar, 12Westra J.G. Kriek E. Hittenhausen H. Chem. Biol. Interact. 1976; 15: 149-164Crossref PubMed Scopus (203) Google Scholar) and the N-(deoxyguanosin-8-yl)-2-aminofluorene DNA adduct in mouse liver(10Lai C.C. Miller J.A. Miller E.C. Liem A. Carcinogenesis. 1985; 6: 1037-1045Crossref PubMed Scopus (113) Google Scholar). In addition, carcinogen-mediated loss of this activity among rat liver cells, putatively initiated for carcinogenesis, has been suggested to contribute to the development of a resistance phenotype to carcinogen toxicity(9Ringer D.P. Norton T.R. Cox B. Howell B.A. Cancer Lett. 1988; 40: 247-255Crossref PubMed Scopus (15) Google Scholar, 13Farber E. Cancer Res. 1984; 44: 5463-5474PubMed Google Scholar). This phenotype contributes to the selective clonal proliferation of initiated cells into preneoplastic nodules during the promotion stage of carcinogenesis (14Ringer D.R. Howell B.A. Norton T.R. Woulfe G.W. Duffel M.W. Kosanke S.D. Mol. Carcinogen. 1994; 9: 2-9Crossref PubMed Scopus (5) Google Scholar). 3′-phosphoadenosine-5′-phosphosulfate aryl sulfotransferase hydroxylamine sulfotransferase high performance liquid chromatography N-hydroxy-2-acetylaminofluorene liquid chromatography phenol sulfotransferase polyacrylamide gel electrophoresis. Rapid advances in the knowledge of the molecular structure of sulfotransferases (see (15Khan A.S. Taylor B.R. Chung K. Etheredge J. Gonzales R. Ringer D.P. Gene (Amst.). 1993; 137: 321-326Crossref PubMed Scopus (22) Google Scholar), and references therein) have stimulated efforts to associate the individual catalytic activities with specific sulfotransferase amino acid sequences(4Meerman J.H.N. Runge-Morris M.A. Coughtrie M.W.H. Chem. Biol. Interact.1994: 1-378Google Scholar). It has been suggested previously that a principal source for liver cytosolic N-OH-2AAF sulfotransferase activity is aryl sulfotransferase IV (AST IV)(1Jakoby W.B. Sekura R.D. Lyon E.S. Marcus C.J. Wang J. Jacoby W.B. Enzymatic Basis of Detoxication. Academic Press, New York1980: 199-228Crossref Google Scholar, 16Sekura R.D. Jakoby W.B. Arch. Biochem. Biophys. 1981; 211: 352-359Crossref PubMed Scopus (100) Google Scholar, 17Ringer D.P. Norton T.R. Howell B.A. Cancer Res. 1990; 50: 5301-5307PubMed Google Scholar, 18Mangold B.L.K. Ericson J. Lorh C. McCann D.J. Mangold J.B. Carcinogenesis. 1990; 11: 1563-1567Crossref PubMed Scopus (10) Google Scholar). This enzyme was reported to be a dimeric molecule comprised of two identical subunits of known amino acid sequence and a subunit mass of 33,906 Da(19Yerokun T. Etheredge J.L. Norton T.R. Carter H.A. Chung K.H. Birckbichler P. Ringer D.P. Cancer Res. 1992; 52: 4779-4786PubMed Google Scholar, 20Chen X. Yang Y.-S. Zheng Y. Martin B.M. Duffel M.W. Jakoby W.B. Protein Exp. Purif. 1992; 3: 421-426Crossref PubMed Scopus (35) Google Scholar). The primary sequence for the AST IV subunit is identical to the deduced amino acid sequences reported for cDNAs of phenol sulfotransferase (PST-I; (21Ozawa S. Nagata K. Gong D. Yamazoe Y. Kato R. Nucleic Acids Res. 1990; 18: 4001Crossref PubMed Scopus (85) Google Scholar)) and for minoxidil sulfotransferase(22Hirshey S.J. Dooley T.P. Reardon I.M. Heinrikson R.L. Falany C.N. Mol. Pharmacol. 1992; 42: 257-264PubMed Google Scholar). Recently, two additional sources of liver cytosolic N-OH-2AAF activity have been reported, HAST-I and HAST-II(23Gong D.W. Ozawa S. Yamazoe Y. Kato R. J. Biochem. (Tokyo). 1991; 110: 226-231Crossref PubMed Scopus (30) Google Scholar). HAST-II was shown to have a higher enzymatic activity toward N-OH-2AAF than HAST-I and to be cross-reactive with a polyclonal antibody raised against HAST-I. Recently, the HAST-I polyclonal antibody was used to isolate an HAST-I cDNA clone, ST1C1(24Nagato K. Ozawa S. Miyata M. Shimade M. Gong D.-W. Yamazoe Y. Kato R. J. Biol. Chem. 1993; 268: 24720-24725Abstract Full Text PDF PubMed Google Scholar). This cDNA was found to code for a 35,768-Da protein that displayed high N-OH-2AAF sulfoconjugation activity when transfected and expressed in COS-1 cells. The 36-kDa HAST-I protein was found to have a 51% amino acid sequence homology with the 34-kDa PST-1/AST IV protein. In order to further evaluate the role of AST IV as an N-OH-2AAF sulfotransferase, studies were conducted to determine the possible contribution of the 34-kDa and 36-kDa sulfotransferase subunits to AST IV activity. The use of improved purification techniques and protein characterization methodologies have revealed the presence of three sulfotransferase forms. The first form is a homodimer of two 33.9-kDa subunits, which shows low N-OH-2AAF sulfotransferase activity. A second form is a homodimer comprised of two 35.7-kDa subunits and has the highest level of N-OH-2AAF sulfotransferase activity. The third form is a heterodimer comprised of a 33.9-kDa and a 35.7-kDa protein subunit, possessing high catalytic activity for N-OH-2AAF sulfonation. The existence of heterodimeric sulfotransferases constitutes a new, previously unreported level of sulfotransferase organization. DEAE-Sepharose Fast Flow, MonoQ HR 5/5 anion exchange column, PhastGel 10-15% gradient polyacrylamide gels, and nitrocellulose membranes were purchased from Pharmacia Biotech Inc. Ceramic hydroxylapatite, Tris-HCl, and all Western blot immunochemical reagents were purchased from Bio-Rad. A Reliasil C18 300-Å, 5 μM (2 mm × 15 cm) reversed phase HPLC column was purchased from Michrom Bioresources (Pleasanton, CA). A BioSep SEC-S2000 HPLC column (7.8 × 300 mm) was obtained from Phenomenex (Torrance, CA). Waters Protein PAK DEAE-5PW (2.15 × 15 cm) HPLC column was purchased from Millipore (Bedford, MA). N-OH-2AAF was purchased from Chemsyn Science Laboratories (Lenexa, KS). PAPS was obtained from Dr. Sanford Singer of and were purchased from was purchased from was purchased from was purchased from and all were obtained from sulfotransferases were from of by a of Ringer D.P. Norton T.R. Howell B.A. Cancer Res. 1990; 50: 5301-5307PubMed Google Scholar). In chromatography was previously reported gradient DEAE-Sepharose Fast and for and respectively. in N-OH-2AAF sulfonation activity were and in sulfonation activity were and were and to as D.P. Norton T.R. Howell B.A. Cancer Res. 1990; 50: 5301-5307PubMed Google Scholar). and were against of A Tris-HCl, and and to a MonoQ HR 5/5 anion exchange was with a gradient of A and A The gradient was as was by an with to in to in 5 with by in A. for analysis was and was of were and were and protein by of 15 was used for a protein Protein and New Scholar). N-OH-2AAF sulfonation activity was by HPLC the of Yamazoe Y. S. Kato R. Mol. Pharmacol. Google Scholar) with In a contained μM Tris-HCl, μM and of sulfotransferase of a chromatography in a of Reactions were for and by the of of N-OH-2AAF sulfoconjugation was by N-OH-2AAF sulfotransferase activity was a in which the sulfuric acid of with D.P. Norton T.R. Howell B.A. Cancer Res. 1990; 50: 5301-5307PubMed Google Scholar). The of sulfotransferase activity by Jacoby 1981; PubMed Scopus Google Scholar) was used to of sulfotransferases during column sulfotransferase activity was as by Gong D.W. Ozawa S. Yamazoe Y. Kato R. J. Biochem. (Tokyo). 1991; 110: 226-231Crossref PubMed Scopus (30) Google Scholar). Reactions were initiated by the of enzyme and for and the was by The for sulfotransferases were from a for the A PubMed Scopus Google Scholar). The Q1 and Q3 used for analysis contained than 33.9-kDa and 35.7-kDa subunit respectively. of ASTs were by C18 reversed phase HPLC a Waters with a column and the chromatography was a of and a column of was The column was analysis with an of and acid A gradient was with acid in as was by a with gradient was from to in to in for by with C. sulfotransferases were an mass model were by first from C18 reversed phase HPLC by into the mass were in the spectrometry by of an HPLC Bioresources with a mm × Reliasil C18 reversed phase The column was with acid and in and the was into the mass with a gradient of acid and in Size exclusion HPLC analysis was a Waters and the were with a Tris-HCl, and The was and was of were for activity and analysis. as was by the of Gong D.W. Ozawa S. Yamazoe Y. Kato R. J. Biochem. (Tokyo). 1991; 110: 226-231Crossref PubMed Scopus (30) Google Scholar). Waters by the were used for gradient and was a Waters of were and for and N-OH-2AAF sulfoconjugation activity as of was a Pharmacia the of Ringer D.P. Norton T.R. Howell B.A. Cancer Res. 1990; 50: 5301-5307PubMed Google Scholar). of of protein were to the were to a nitrocellulose the Pharmacia the nitrocellulose was with and were for 5 immunochemical of sulfotransferases was the and as D.P. Norton T.R. Howell B.A. Cancer Res. 1990; 50: 5301-5307PubMed Google Scholar). were a analysis In the sulfotransferase polyclonal primary antibody was with 35.7-kDa protein to of the 35.7-kDa of antibody was used to the polyclonal antibody for the with the of C18 reversed phase protein were with for in the presence of acid sequence were a model protein with a model amino acid to M.W. J. Biol. Chem. 1981; Full Text PDF PubMed Google Scholar). was of amino acid sequences with the previously deduced amino acid sequences for (21Ozawa S. Nagata K. Gong D. Yamazoe Y. Kato R. Nucleic Acids Res. 1990; 18: 4001Crossref PubMed Scopus (85) Google Scholar) and ST1C1(24Nagato K. Ozawa S. Miyata M. Shimade M. Gong D.-W. Yamazoe Y. Kato R. J. Biol. Chem. 1993; 268: 24720-24725Abstract Full Text PDF PubMed Google Scholar). The principal for the purification of AST IV R.D. Jakoby W.B. Arch. Biochem. Biophys. 1981; 211: 352-359Crossref PubMed Scopus (100) Google Scholar) of AST IV from the AST and by by of AST IV from the AST form by of AST IV from the protein was by PAPS from an in is a protein from the column in which two of sulfotransferase activity are and R.D. Jakoby W.B. Arch. Biochem. Biophys. 1981; 211: 352-359Crossref PubMed Scopus (100) Google Scholar), the first to AST whereas the second to the previously AST The and were further by and are shown in showed sulfotransferase activity for and with AST IV activity for N-OH-2AAF and activity for a of when for protein with polyclonal raised against AST IV in with D.P. Norton T.R. Howell B.A. Cancer Res. 1990; 50: 5301-5307PubMed Google Scholar, M.W. T.P. H.A. J.A. J. Mol. Pharmacol. 1991; 40: Google Scholar) the possible existence of forms of AST and were to MonoQ anion exchange shown in (AST and were into three of sulfotransferase activity, Q1, Q2, and Q3 the of of for N-OH-2AAF sulfotransferase activity showed activity for Q1 and Q2, whereas Q3 had low In sulfotransferase activity was found to be in Q1 than in Q2 and Q3. the and enzymatic analysis of Q1, Q2, and Q3 showed was comprised of a 34-kDa and were from AST determine the for the in AST IV and of the sulfotransferase the protein for Q1, Q2, and Q3 were by high performance exclusion shown in the results of this analysis indicated that the activity of all three with the further evaluate the for the Q1, Q2, and Q3 subunit was by the dimeric forms to C18 reversed phase showed that Q1 and Q3 were comprised of a protein with In the Q2 contained two protein of which to the Q1 and Q3 reversed phase liquid chromatography and mass spectrometry of protein found in Q1, Q2, and Q3 indicated that Q1 contained a with a mass of and that Q3 was comprised of a with a mass of spectrometry of the two protein in Q2 were found to have identical to the for Q1 and Q3. The mass for the Q3 protein the mass of an form of the deduced amino acid sequence from the S. Nagata K. Gong D. Yamazoe Y. Kato R. Nucleic Acids Res. 1990; 18: 4001Crossref PubMed Scopus (85) Google Scholar), The mass of the protein Q1 with reported sulfotransferase amino acid it displayed high N-OH-2AAF activity, the that it was a form of the subunit K. Ozawa S. Miyata M. Shimade M. Gong D.-W. Yamazoe Y. Kato R. J. Biol. Chem. 1993; 268: 24720-24725Abstract Full Text PDF PubMed Google Scholar). the of the of the subunit in a mass of spectrometry analysis of the protein subunits the sulfotransferase Q1, Q2, and Q3. mass by mass spectrometry of the subunit A and isolated by C18 reversed phase HPLC of Q1, Q2, and was as A mass and are shown for A and further the of the sulfotransferase subunits found in Q1, Q2, and amino acid was subunit subunits were found to be and were to by of and analysis of for amino acid shown in amino acid of showed that the subunit Q1 was to K. Ozawa S. Miyata M. Shimade M. Gong D.-W. Yamazoe Y. Kato R. J. Biol. Chem. 1993; 268: 24720-24725Abstract Full Text PDF PubMed Google Scholar) and the subunit for Q3 was to S. Nagata K. Gong D. Yamazoe Y. Kato R. Nucleic Acids Res. 1990; 18: 4001Crossref PubMed Scopus (85) Google Scholar). These that cytosolic N-OH-2AAF sulfotransferase activity is a of the activities of three forms in which Q1 is an Q2 is an and Q3 is a in a The relative sulfotransferase of the three AST IV were N-OH-2AAF and as of Q1 and Q3 used for analysis contained than 33.9-kDa and 35.7-kDa subunit, respectively. Q1-Q3 were whereas a Q1 had the highest whereas Q2, the had of Q1, and Q3 had a that was than that of The as show a The for Q3 was than for Q1 and The were with The high level of N-OH-2AAF sulfotransferase activity for Q1, the and the low activity found in the indicated that the subunit was the primary source for this activity in AST in a were to the contribution of Q1, Q2, and Q3 to cytosolic N-OH-2AAF activity and the presence of heterodimer in to purification liver was a column and for the presence of to Q1, Q2, and Q3. shown in analysis of for N-OH-2AAF and sulfotransferase activity showed three These in to the previously for Q1, Q2, and Q3. The relative contributions to total cytosolic N-OH-2AAF sulfotransferase activity were and 10% for the Q1, Q2, and Q3 respectively. The of the Q1-Q3 were confirmed by immunochemical analysis of to the of of the three These were to and Western blot immunochemical analysis a polyclonal antibody to AST IV that had been with the subunit shown in of the polyclonal to AST IV with subunit was to to the for the of subunit. these were shown to be for use in liver cytosols and of the with both subunits of sulfotransferase in to shown in and the first activity which showed high N-OH-2AAF sulfonation activity and only for the presence of the subunit. The second which showed of both sulfotransferase for the presence of both the and subunits. The which showed high sulfonation activity and low of N-OH-2AAF sulfonation activity, only for the presence of the subunit. These results the existence of Q2 in the and the that Q2 is an source of N-OH-2AAF sulfotransferase activity in analysis of sulfotransferase subunit compositions of from of The from the sulfotransferase Q1, Q2, and Q3 in were by Western blot analysis for the presence of the 33.9-kDa and 35.7-kDa subunits. a the of the polyclonal to be used for of the two and of 33.9-kDa of 35.7-kDa and of protein. was with polyclonal antibody as and with 33.9-kDa and with both 33.9-kDa and 35.7-kDa subunits. In and contained of Q1, Q2, and respectively. The immunochemical was with sulfotransferase polyclonal with 33.9-kDa subunit in and 35.7-kDa subunit in for additional The N-OH-2AAF sulfotransferase activity of rat liver AST IV has been shown to be comprised of the activities of three with and The three Q1, Q2, and were by AST IV to high performance liquid chromatography with an anion exchange was shown to have N-OH-2AAF sulfotransferase activity, and a 34-kDa that Western immunochemical with polyclonal to AST of the individual AST IV to by reversed phase HPLC showed that had a subunit and reversed phase HPLC as an for of analysis of the subunits by mass spectrometry and amino acid a for the of the three This has a of sulfotransferase subunit Q1 was shown to be a homodimer comprised of a protein subunit, amino acid sequence was found to be to the sulfotransferase subunit K. Ozawa S. Miyata M. Shimade M. Gong D.-W. Yamazoe Y. Kato R. J. Biol. Chem. 1993; 268: 24720-24725Abstract Full Text PDF PubMed Google deduced amino acid sequence molecular mass of Q1 showed high N-OH-2AAF sulfotransferase activity and to the sulfotransferase the subunit K. Ozawa S. Miyata M. Shimade M. Gong D.-W. Yamazoe Y. Kato R. J. Biol. Chem. 1993; 268: 24720-24725Abstract Full Text PDF PubMed Google Scholar). The Q3 was shown to be a homodimer comprised of a protein subunit with a molecular mass of and amino acid sequence that it as the sulfotransferase subunit S. Nagata K. Gong D. Yamazoe Y. Kato R. Nucleic Acids Res. 1990; 18: 4001Crossref PubMed Scopus (85) Google deduced amino acid sequence molecular mass of 33,906 It showed N-OH-2AAF sulfotransferase than the Q1 homodimer and had been implicated previously as a source of N-OH-2AAF sulfotransferase R.D. Jakoby W.B. Arch. Biochem. Biophys. 1981; 211: 352-359Crossref PubMed Scopus (100) Google Scholar, T. Etheredge J.L. Norton T.R. Carter H.A. Chung K.H. Birckbichler P. Ringer D.P. Cancer Res. 1992; 52: 4779-4786PubMed Google Scholar). The Q2 was found to be a heterodimer comprised of 35.7-kDa subunit and 33.9-kDa subunit It a high N-OH-2AAF sulfotransferase which was that of the homodimer Q2 to have an anion exchange chromatography to that of a sulfotransferase which had been previously as N-OH-2AAF sulfotransferase activity and to an raised against D.W. Ozawa S. Yamazoe Y. Kato R. J. Biochem. (Tokyo). 1991; 110: 226-231Crossref PubMed Scopus (30) Google Scholar). analysis of the N-OH-2AAF sulfotransferase activities for the three indicated that the homodimer was than the homodimer and than the heterodimer analysis of sulfotransferase activities among the three indicated a of catalytic The homodimer was than the homodimer and than the heterodimer These results indicated that have a role in catalytic these studies indicated that sulfoconjugation of N-OH-2AAF to highly reactive sulfuric acid form was by a sulfotransferase the in vivo contribution of the forms was relative and be into reported analysis of suggested that the heterodimer was a principal source of N-OH-2AAF sulfotransferase activity in of Q2 as an heterodimer constitutes the first of a heterodimeric have been shown to be in from the of by heterodimeric 1991; Full Text PDF PubMed Scopus Google Scholar, S.J. 1994; Full Text PDF PubMed Scopus Google Scholar) to the of by heterodimeric detoxication Rev. Biochem. PubMed Scopus Google Scholar). heterodimer the specific activity of for In the of xenobiotic as heterodimeric that the of K. Cancer Res. 52: PubMed Scopus Google Scholar). The xenobiotic of in have been shown to be a of H. B. B. Carcinogenesis. PubMed Scopus Google Scholar) T. D.J. J. Biol. Chem. 1994; Full Text PDF PubMed Google Scholar) of subunit in of catalytic and the existence of heterodimeric sulfotransferases a level of for this of detoxication is that of sulfotransferases in rat liver are in a J.R. Miller E.C. Miller J.A. Cancer Res. 1970; 30: 577-595PubMed Google Scholar, 17Ringer D.P. Norton T.R. Howell B.A. Cancer Res. 1990; 50: 5301-5307PubMed Google Scholar, D.W. Ozawa S. Yamazoe Y. Kato R. J. Biochem. (Tokyo). 1991; 110: 226-231Crossref PubMed Scopus (30) Google Scholar, K. Ozawa S. Miyata M. Shimade M. Gong D.-W. Yamazoe Y. Kato R. J. Biol. Chem. 1993; 268: 24720-24725Abstract Full Text PDF PubMed Google Scholar, A. J.A. Carcinogenesis. 1991; Scopus Google Scholar). the rat liver sulfotransferases and have been reported to be and D.W. Ozawa S. Yamazoe Y. Kato R. J. Biochem. (Tokyo). 1991; 110: 226-231Crossref PubMed Scopus (30) Google Scholar). these as suggested to Q1 and Q2 it be that the higher N-OH-2AAF sulfotransferase activity in liver cytosols J.R. Miller E.C. Miller J.A. Cancer Res. 1970; 30: 577-595PubMed Google Scholar, 17Ringer D.P. Norton T.R. Howell B.A. Cancer Res. 1990; 50: 5301-5307PubMed Google Scholar, D.W. Ozawa S. Yamazoe Y. Kato R. J. Biochem. (Tokyo). 1991; 110: 226-231Crossref PubMed Scopus (30) Google Scholar) from the presence of the and forms. studies to the for sulfotransferase subunit and the to which are to further into the that sulfotransferases have in xenobiotic The existence of heterodimeric sulfotransferases a level of as an enzyme among is to subunits with of Rev. Biochem. PubMed Scopus Google Scholar, K. Cancer Res. 52: PubMed Scopus Google Scholar). In the amino acid sequence homology the subunits for the and is reported to be only K. Ozawa S. Miyata M. Shimade M. Gong D.-W. Yamazoe Y. Kato R. J. Biol. Chem. 1993; 268: 24720-24725Abstract Full Text PDF PubMed Google Scholar). have been of the for sulfotransferase and and is known the sulfotransferase responsible for as sulfotransferase heterodimer is to specific of sulfotransferases is a of all sulfotransferases are for spectrometry analysis and protein sequence were by The of the K. the of Dr. with the mass spectrometry and Dr. for the analysis. Dr. S. for of the of in the of the
27
A gas-liquid solid phase peptide and protein sequenator.
Rodney M. Hewick, Michael W. Hunkapiller, Leroy Hood et al. · Journal of Biological Chemistry · 1981 · 2.2K citations · Full text